High Serum Levels of iNOS and MIP-1α are Associated with Post-Stroke Depression
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Purpose: Post-stroke depression (PSD) is one of the emotional disorders after the onset of stroke. Many studies have indicated that inflammatory processes can promote the occurrence and development of PSD. The purpose of our study was to explore the potential relationship between PSD and two inflammatory biomarkers: inducible nitric oxide synthase (iNOS) and macrophage inflammatory protein 1α (MIP-1α). Methods: In total, 80 patients diagnosed with depression after the first-ever acute ischemic stroke were enrolled in PSD group consecutively. During the same period, 40 non-depressed patients following the first-ever acute ischemic stroke and 40 healthy control subjects were recruited as non-PSD group and normal group, respectively. All participants have performed serum iNOS and MIP-1α level examination with enzyme-linked immunosorbent assay (ELISA). The severity of depressive symptoms was evaluated by the 24-item Hamilton Depression Scale (HAMD-24). Results: Serum iNOS and MIP-1α levels were significantly higher in PSD group than those in non-PSD and normal groups ( P < 0.001). Serum iNOS and MIP-1α levels of PSD patients with varying degrees of depression were significantly different, serum iNOS and MIP-1α levels became higher as the depressive symptoms became more severe ( P < 0.05). There was a positive correlation between the elevated levels of iNOS, MIP-1α and HAMD scores ( r = 0.262, 0.209, P < 0.05). Logistic regression analysis showed that both serum iNOS and MIP-1α levels were independently associated with PSD (OR = 2.790, 95% CI: 0.712– 10.933, P < 0.05 and OR = 1.922, 95% CI: 0.648– 9.815, P < 0.05, respectively) after adjustment for possible relevant confounders. Conclusion: High serum levels of iNOS and MIP-1α were found to be associated with the development of PSD and closely related to its severity. Keywords: post-stroke depression, inducible nitric oxide synthase, macrophage inflammatory protein 1α, HAMD scores
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A more recent study demonstrated that elevated serum levels of MIP-1α and iNOS are associated with post-stroke depression [187].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Campbell, B. C. V., De Silva, D. A., Macleod, M. R., Coutts, S. B., Schwamm, L. H., Davis, S. M., & Donnan, G. A. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0118-8 · Cited by 1,750 · cited 1×
“and treatment of stroke, it remains an urgent problem to be solved due to its high recurrence rate and serious complications.(2,3) Stroke survivors tend to be left with different degrees of physical and psychiatric disabilities.”
Severity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199 · cited 1×
“The PSD group was divided into mild PSD group (8–16), moderate PSD group (17–23) and severe PSD group (≥ 24) according to HAMD scores.(22) During the same period, 40 non-depressed patients after the first-ever acute ischemic stroke and 40 healthy control subjects were recruited as non-PSD group and normal group, respe…”
MethodCampbell, B. C. V., & Khatri, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31179-x · Cited by 1,116
National Institutes of Health Stroke Scale (NIHSS)
Kwah, L. K., & Diong, J. (2014) · Journal of Physiotherapy · doi:10.1016/j.jphys.2013.12.012 · Cited by 811
The physiology and pathophysiology of nitric oxide in the brain
Guix, F. X., Uribesalgo, I., Coma, M., & Muñoz, F. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.001 · Cited by 713 · cited 1×
“It has been found that both iNOS and MIP-1α play a vital role in the occurrence of depressive disorders and the levels of them were increased.(25,26) However, there is no direct evidence to confirm the association between iNOS and MIP-1α levels and depression after acute stroke.”
BackgroundNitric Oxide in the Nervous System
Zhang, J., & Snyder, S. H. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.001241 · Cited by 513 · cited 2×
“Of the three isoforms of NOSs, inducible nitric oxide synthase (iNOS) is mainly involved in the production of NO under inflammatory conditions and particularly relevant to neuropsychiatric disorders.(9) Some studies have suggested that iNOS can induce the occurrence and development of depression through neuroinflammat…”
BackgroundPost stroke depression: epidemiology, pathophysiology, and biological treatment
Whyte, E. M., & Mulsant, B. H. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01424-5 · Cited by 488 · cited 1×
“The main clinical symptoms of PSD include somnipathy, depression, anxiety and even suicide.(6) The etiology and Correspondence: Fuping Shi Department of Neurology, Affiliated Hospital of Hebei University, No.”
BackgroundWhat is a mental/psychiatric disorder? From DSM-IV to DSM-V
Stein, D. J., Phillips, K. A., Bolton, D., Fulford, K. W. M., Sadler, J. Z., & Kendler, K. S. (2010) · Psychological Medicine · doi:10.1017/s0033291709992261 · Cited by 477 · cited 1×
“(5th edition) (DSM-V).(21) The 80 patients diagnosed with depression after the first-ever acute ischemic stroke were enrolled in PSD group.”
BackgroundCai, W., Mueller, C., Li, Y.-J., Shen, W.-D., & Stewart, R. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.013 · Cited by 359 · cited 1×
“sion (PSD), more than one-third of stroke survivors experience varying degrees of depressive symptoms at any time during follow-up.(5) The main clinical symptoms of PSD include somnipathy, depression, anxiety and even suicide.”
BackgroundHerken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322 · cited 1×
“The primary mechanism about increased iNOS levels affecting the occurrence and development of PSD is that iNOS can induce excess NO production which can produce neurotoxicity under the action of reactive oxygen species (ROS) and reactive nitrogen species (RNS).(27,28) Excess NO can further damage brain tissue and inac…”
BackgroundPost stroke depression: the sequelae of cerebral stroke
Das, J., & G.K., R. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.005 · Cited by 301 · cited 1×
“pathogenesis of PSD are multifactorial and have not been fully understood.(7) Therefore, it is of great significance to reveal more detailed pathophysiological mechanisms and find more convincing biological markers about PSD.”
BackgroundA detailed examination of cytokine abnormalities in Major Depressive Disorder
Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.004 · Cited by 286 · cited 1×
“With regard to clinical practice, several studies found that MIP-1α levels became higher as the depressive symptoms became more severe.(37,38) Another research suggested that the levels of MIP-1α were increased in depressed patients with cognitive disorders.”
ResultLindqvist, D., Hall, S., Surova, Y., Nielsen, H. M., Janelidze, S., Brundin, L., & Hansson, O. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.07.007 · Cited by 276
Nitric oxide and major depression
Dhir, A., & Kulkarni, S. K. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.02.002 · Cited by 235 · cited 1×
“The primary mechanism about increased iNOS levels affecting the occurrence and development of PSD is that iNOS can induce excess NO production which can produce neurotoxicity under the action of reactive oxygen species (ROS) and reactive nitrogen species (RNS).(27,28) Excess NO can further damage brain tissue and inac…”
BackgroundSuarez, E. C., Krishnan, R. R., & Lewis, J. G. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000035719.79068.2b · Cited by 199
Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide
Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.022 · Cited by 198
Inflammatory theory of depression
Gałecki, P., & Talarowska, M. (2018) · Psychiatria Polska · doi:10.12740/pp/76863 · Cited by 192
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence
Ferrari, F., & Villa, R. F. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0032-y · Cited by 186
Hypoxic-Ischemic Injury Induces Macrophage Inflammatory Protein-1α Expression in Immature Rat Brain
Cowell, R. M., Xu, H., Galasso, J. M., & Silverstein, F. S. (2002) · Stroke · doi:10.1161/hs0302.103740 · Cited by 150
Immune changes and neurotransmitters: Possible interactions in depression?
Sperner‐Unterweger, B., Kohl, C. A., & Fuchs, D. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.006 · Cited by 145 · cited 1×
“On the other hand, under the condition of the low production of biogenic amines (such as serotonin and dopamine, both of them are associated with emotion regulation), iNOS can produce more ROS and RNS which can further aggravate the depressive symptoms.(34) As a hippocampal neuromodulator, MIP-1α can regulate synaptic…”
BackgroundPrevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor
Wang, D., An, S. C., & Zhang, X. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.041 · Cited by 140 · cited 1×
“Moreover, a study suggested that injecting iNOS inhibitor aminoguanidine into one side of the hippocampus significantly inhibited depression-like behaviors induced by chronic unpredictable mild stress (CUMS).(13) Another study found that after antidepressant treatment in a vivo model of depression, the production of N…”
BackgroundPang, L., Ye, W., Che, X.-M., Roessler, B. J., Betz, A. L., & Yang, G.-Y. (2001) · Stroke · doi:10.1161/01.str.32.2.544 · Cited by 135 · cited 1×
“Under the condition of ischemia and hypoxia, MIP-1α is increased and mainly comes from microglia cells which are the most significant number of white blood cells in brain tissue during ischemic brain injury.(35,36) Stroke is a kind of ischemia and hypoxia disease, our study found that the MIP-1α levels of stroke patie…”
ResultDhir, A., & Kulkarni, S. K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.028 · Cited by 133 · cited 1×
“In addition, some investigations have confirmed that the expression of iNOS was increased in depressed patients.(11,12) Moreover, a study suggested that injecting iNOS inhibitor aminoguanidine into one side of the hippocampus significantly inhibited depression-like behaviors induced by chronic unpredictable mild stres…”
Terroni, L. D. M. N., Amaro, E., Iosifescu, D. V., Tinone, G., Sato, J. R., Leite, C. C., Sobreiro, M. D. F. M., de Lúcia, M. C. S., Scaff, M., & Fráguas, R. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.562242 · Cited by 122
Miyazaki, D., Nakamura, T., Toda, M., Cheung-Chau, K.-W., Richardson, R. M., & Ono, S. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci18452 · Cited by 112
Dhir, A., & Kulkarni, S. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.02.008 · Cited by 101 · cited 1×
“Previous studies have found that the L-arginine-NOcyclic guanosine monophosphate (cGMP) signaling pathway participates in the pathogenesis of mood disorders including depression.(8) As a signal molecule, nitric oxide (NO) can be synthesized by three isoforms of nitric oxide synthases (NOSs) and can regulate behavioral…”
BackgroundAJUEBOR, VIRÁG, FLOWER, PERRETTI, & SZABÓ (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00644.x · Cited by 99 · cited 1×
“After inducing the production of NO in the wild-type mice, the levels of MIP-1α was increased, but for the iNOS gene knockout mice, the release of MIP-1α was not affected.(18) Moreover, the expression of MIP-1α was significantly inhibited by NOS inhibitor.”
BackgroundInterleukin-17 in post-stroke neurodegeneration
Swardfager, W., Winer, D. A., Herrmann, N., Winer, S., & Lanctôt, K. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.021 · Cited by 94 · cited 1×
“In recent years, many studies have shown that inflammation responses play a crucial role in the pathophysiology of PSD, the expression of inflammatory markers was increased in the depressive disorders after stroke.(24) It has been found that both iNOS and MIP-1α play a vital role in the occurrence of depressive disord…”
BackgroundYang, L., Zhang, Z., Sun, D., Xu, Z., Yuan, Y., Zhang, X., & Li, L. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2552 · Cited by 86
Rates and correlates of suicidal ideation among stroke survivors: a meta-analysis
Bartoli, F., Pompili, M., Lillia, N., Crocamo, C., Salemi, G., Clerici, M., & Carrà, G. (2017) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-315660 · Cited by 76 · cited 1×
“Stroke survivors tend to be left with different degrees of physical and psychiatric disabilities.(4) In recent years, psychic”
BackgroundCepeda, M. S., Stang, P., & Makadia, R. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10267 · Cited by 75 · cited 1×
“Besides, it can promote the inflammatory responses associated with depression and up-regulate the expression of inflammatory cytokines.(29,30) Moreover, inflammatory cytokines can induce iNOS gene expression and the production of NO.”
BackgroundZhou, X. Y., Zhang, F., Ying, C., Chen, J., Chen, L., Dong, J., Shi, Y., Tang, M., Hu, X. T., Pan, Z. H., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.12.046 · Cited by 64 · cited 1×
“The possible mechanism is that inhibiting iNOS signaling pathway may alleviate depressive symptoms by exerting anti-inflammatory and neuroprotective effects.(15) Macrophage inflammatory protein 1α (MIP-1α) belongs to a member of the CC subfamily of chemokines and its release is considered a crucial process in the recr…”
BackgroundNitric Oxide and Major Depressive Disorder: Pathophysiology and Treatment Implications
Kudlow, P., Cha, D. S., Carvalho, A. F., & McIntyre, R. S. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144722 · Cited by 63 · cited 1×
“Besides, it can promote the inflammatory responses associated with depression and up-regulate the expression of inflammatory cytokines.(29,30) Moreover, inflammatory cytokines can induce iNOS gene expression and the production of NO.”
BackgroundMühl, H., & Dinarello, C. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.5063 · Cited by 52 · cited 1×
“Moreover, the expression of MIP-1α was significantly inhibited by NOS inhibitor.(19) Based on the above evidence, iNOS and MIP-1α may jointly lead to the occurrence of depressive symptoms.”
BackgroundInvolvement of fractalkine and macrophage inflammatory protein‐1 alpha in moderate‐severe depression
Merendino, R. A., Di Pasquale, G., De Luca, F., Di Pasquale, L., Ferlazzo, E., Martino, G., Palumbo, M. C., Morabito, F., & Gangemi, S. (2004) · Mediators of Inflammation · doi:10.1080/09511920410001713484 · Cited by 47 · cited 3×
“It has been suggested that MIP-1α may be involved in the development of depressive symptoms through the recruitment of inflammatory cells.(17) Besides, iNOS can regulate the production of MIP1α.”
BackgroundInfluentialAntidepressant and Anti-Neuroinflammatory Effects of Bangpungtongsung-San
Park, B.-K., Kim, N. S., Kim, Y. R., Yang, C., Jung, I. C., Jang, I., Seo, C., Choi, J. J., & Lee, M. Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00958 · Cited by 44 · cited 1×
“Another study found that after antidepressant treatment in a vivo model of depression, the production of NO was decreased by inhibiting the expression of iNOS.(14) The possible mechanism is that inhibiting iNOS signaling pathway may alleviate depressive symptoms by exerting anti-inflammatory and neuroprotective effect…”
BackgroundLu, D.-Y., Leung, Y.-M., & Su, K.-P. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000338 · Cited by 43 · cited 1×
“In addition, some investigations have confirmed that the expression of iNOS was increased in depressed patients.(11,12) Moreover, a study suggested that injecting iNOS inhibitor aminoguanidine into one side of the hippocampus significantly inhibited depression-like behaviors induced by chronic unpredictable mild stres…”
Ogłodek, E. A. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.08.008 · Cited by 32 · cited 1×
“With regard to clinical practice, several studies found that MIP-1α levels became higher as the depressive symptoms became more severe.(37,38) Another research suggested that the levels of MIP-1α were increased in depressed patients with cognitive disorders.”
ResultGeppert, A. M., Losy, J., Przedpelska-Ober, E., & Kozubski, W. P. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.02.007 · Cited by 22 · cited 2×
“It has been found that both iNOS and MIP-1α play a vital role in the occurrence of depressive disorders and the levels of them were increased.(25,26) However, there is no direct evidence to confirm the association between iNOS and MIP-1α levels and depression after acute stroke.”
BackgroundResultStroke is treatable, but prevention is the key
Algra, A., & Wermer, M. J. H. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.4 · Cited by 20 · cited 1×
“and treatment of stroke, it remains an urgent problem to be solved due to its high recurrence rate and serious complications.(2,3) Stroke survivors tend to be left with different degrees of physical and psychiatric disabilities.”
BackgroundSobering news about post-stroke depression
Kumar, S. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30410-2 · Cited by 6 · cited 1×
“PSD is one of the emotional disorders after the onset of stroke and predicts poor outcomes of stroke.(23) In recent years, many studies have shown that inflammation responses play a crucial role in the pathophysiology of PSD, the expression of inflammatory markers was increased in the depressive disorders after stroke.”
Background
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
Tang, X., Liao, R., Li-jun, Z., Yang, L.-L., Ma, Z.-L., Yi, C., Liu, J., Liu, J.-C., Kuang, Y.-J., Cai, H., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5443 · Cited by 34
RetractedElevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression
Li, Y., Zhang, M., Xue, M., Liu, D., & Sun, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.902022 · Cited by 27
Self-citationLifetime pathogen burden, inflammatory markers, and depression in community-dwelling older adults
Lu, Y., Liu, B.-P., Tan, C. T., Pan, F., Larbi, A., & Ng, T. P. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.02.020 · Cited by 20
NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity
Chen, C., Zhang, S., Sheng, M., & Shao, W. (2025) · Mediators of Inflammation · doi:10.1155/mi/4330574 · Cited by 18
“Studies have shown that in fl ammatory cytokine levels are elevated in both PSD patients and animal models, accompanied by the activation of the TLR4/p38/NF-κ B/NLRP3 pathway [144, 145].”
Metadata
- Authors
- Wang, X., Fang, C., Liu, X., Wei, W., Zhang, M., Chen, S., & Shi, F.
- Affiliations
- Affiliated Hospital of Hebei University (CN)
- Corresponding author
- Shi, Fuping
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2021-07
- Volume
- Volume 17
- Pages
- 2481-2487
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- PMC
- PMC8326775
- OpenAlex
- W3186873814
- Cited by
- 14
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 1
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Hebei University
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- post-stroke depression, inducible nitric oxide synthase, macrophage inflammatory protein-1alpha, serum inflammatory markers, ischemic stroke, depression severity, neuroinflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.